| Period | AGX | SPY | Delta |
|---|---|---|---|
| 3M | +50.3% | +11.4% | +38.9% |
| 6M | +115.7% | +8.2% | +107.6% |
| 1Y | +215.7% | +22.9% | +192.9% |
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| REVENUES | $944.6M+8.1% | $874.2M+52.5% | $573.3M+26.0% | $455.0M-10.7% | $509.4M |
| Cost of revenues | $750.9M+2.4% | $733.2M+48.9% | $492.5M+33.6% | $368.7M-10.0% | $409.6M |
| GROSS PROFIT | $193.7M+37.4% | $141.0M+74.4% | $80.8M-6.4% | $86.4M-13.4% | $99.7M |
| Selling, general and administrative expenses | $59.0M+11.7% | $52.8M+19.0% | $44.4M-0.7% | $44.7M-5.6% | $47.3M |
| INCOME FROM OPERATIONS | $134.7M+52.7% | $88.2M+141.9% | $36.5M-12.5% | $41.7M-6.4% | $44.5M |
| Other income, net | $25.8M+12.2% | $23.0M+84.4% | $12.5M+188.0% | $4.3M+69.7% | $2.6M |
| Total income before income taxes | $160.5M+44.3% | $111.2M+127.3% | $48.9M+6.4% | $46.0M-2.3% | $47.1M |
| Provision for income taxes | $22.7M-11.7% | $25.7M+55.3% | $16.6M+46.7% | $11.3M-0.5% | $11.4M |
| NET INCOME | $137.8M+61.2% | $85.5M+164.1% | $32.4M-6.8% | $34.7M-2.8% | $35.7M |
| Foreign currency translation adjustments | $4.7M+304.1% | -$2.3M-152.4% | -$920K-116.5% | -$425K+69.0% | -$1.4M |
| Net unrealized gains (losses) on available-for-sale securities | $2.6M+522.8% | -$619K-411.1% | $199K | — | — |
| COMPREHENSIVE INCOME | $145.1M+75.9% | $82.5M+160.8% | $31.6M-3.2% | $32.7M-11.4% | $36.9M |
| Basic (in dollars per share) | $10000.00+57.5% | $6350.00+162.4% | $2420.00+3.0% | $2350.00-3.3% | $2430.00 |
| Diluted (in dollars per share) | $9740.00+58.4% | $6150.00+157.3% | $2390.00+2.6% | $2330.00-2.9% | $2400.00 |
| Basic (in shares) | 13.8M+2.4% | 13.4M+0.6% | 13.4M-5.1% | 14.1M-10.4% | 15.7M |
| Diluted (in shares) | 14.1M+1.7% | 13.9M+2.6% | 13.5M-4.4% | 14.2M-10.9% | 15.9M |
| CASH DIVIDENDS PER SHARE | $1750.00+29.6% | $1350.00+22.7% | $1100.00+10.0% | $1000.00+0.0% | $1000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Argan delivered record Q1 FY2027 revenue of $291.0 million with diluted EPS of $3.24, up 102.5% year-over-year, as gross margin expanded to 21.0%
“We delivered a strong start to fiscal 2027 with record revenue of $291 million, gross margin of 21%, diluted earnings per share of $3.24, and adjusted EBITDA of $56.4 million.”
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 2026-04-30 | Getsinger Peter W | Director | Sale | 3,000 | $628.36 | $1.89M | 6,847 | View | |
| 2026-04-29 | 2026-04-30 | Larroque Alexander Lisa | Director | Sale | 350 | $630.58 | $221K | 350 | View | |
| 2026-04-28 | 2026-04-29 | Leimkuhler William F. | Director | Sale | 5,400 | $617.69 | $3.34M | 500 | View | |
| 2026-04-27 | 2026-04-29 | Jeffrey John Ronald Jr. | Director | Sale | 2,698 | $664.84 | $1.79M | 2,000 | View | |
| 2026-04-21 | 2026-04-22 | Collins Charles Edwin IV | CHIEF EXECUTIVE OFFICER, GEMMA | Sale | 11.1K | $621.61 | $6.88M | 30.3K | View |
Informational purposes only, not investment advice.